Suppr超能文献

原发性甲状旁腺功能亢进症骨质疏松患者的骨折风险估计

Estimated fracture risk in osteopenic patients with primary hyperparathyroidism.

作者信息

Castellano Elena, Garelli Anna, Attanasio Roberto, Boriano Alberto, Borretta Giorgio

机构信息

Department of Endocrinology, Diabetes and Metabolism, Santa Croce and Carle Hospital, Via Michele Coppino 26, Cuneo, 12100, Italy.

Scientific Committee, Associazione Medici Endocrinologi, Verona, Italy.

出版信息

Endocrine. 2025 Sep 10. doi: 10.1007/s12020-025-04406-5.

Abstract

BACKGROUND

While osteoporosis in primary hyperparathyroidism (PHPT) is widely studied, PHPT patients with osteopenia remain less characterized. This study aimed to evaluate the prevalence, biochemical features, and estimated fracture risk of osteopenic PHPT patients in a real-life cohort.

METHODS

We retrospectively analyzed a consecutive series of PHPT patients with available densitometric data at three sites. Postmenopausal women and men over 50 years old with PHPT and osteopenia were selected. FRAX scores were used to estimate fracture risk, and subgroup analyses were conducted based on sex, age, and PHPT clinical presentation.

RESULTS

One hundred out of 439 PHPT patients (22.8%) were osteopenic. As compared to osteopenic women, osteopenic men were older (p = 0.03), had higher BMD at the spine and femoral neck (p = 0.007 and p = 0.006, respectively), and more frequent occurrence of nephrolithiasis (p = 0.046). Osteopenic patients older than 65 years had worst FRAX scores and higher prevalence of comorbidities, as type 2 diabetes and hypertension, than their younger counterparts (both p < 0.001). FRAX scores of osteopenic PHPT patients were not different according to their clinical classification of PHPT.

CONCLUSIONS

Patients with osteopenia account for about one fifth of our whole series and two thirds of them met surgical indication according to latest international guidelines. Neither densitometric data nor estimated fracture risk differed between osteopenic PHPT patients meeting or not surgical criteria.

摘要

背景

虽然原发性甲状旁腺功能亢进症(PHPT)中的骨质疏松症已得到广泛研究,但骨量减少的PHPT患者的特征仍不太明确。本研究旨在评估现实生活队列中骨量减少的PHPT患者的患病率、生化特征和估计骨折风险。

方法

我们回顾性分析了一系列连续的PHPT患者,这些患者在三个部位均有可用的骨密度数据。选取了患有PHPT和骨量减少的绝经后女性及50岁以上男性。使用FRAX评分来估计骨折风险,并根据性别、年龄和PHPT临床表现进行亚组分析。

结果

439例PHPT患者中有100例(22.8%)骨量减少。与骨量减少的女性相比,骨量减少的男性年龄更大(p = 0.03),脊柱和股骨颈的骨密度更高(分别为p = 0.007和p = 0.006),肾结石的发生率更高(p = 0.046)。65岁以上的骨量减少患者的FRAX评分最差,合并症(如2型糖尿病和高血压)的患病率高于年轻患者(均p < 0.001)。骨量减少的PHPT患者的FRAX评分根据其PHPT的临床分类并无差异。

结论

骨量减少的患者约占我们整个系列的五分之一,其中三分之二的患者根据最新国际指南符合手术指征。符合或不符合手术标准的骨量减少的PHPT患者的骨密度数据和估计骨折风险均无差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验